Sickle cell disease (SCD)‐related organ complications are a major cause of morbidity and
mortality in patients with SCD. We sought to assess whether hematopoietic stem cell …

Background Hydroxyurea is an affordable drug that reduces vaso-occlusive crises and
transfusion requirements in sickle cell disease. However, its effectiveness in preventing …

Background Among individuals with sickle cell disease (SCD), decreased hemoglobin is
associated with lower oxygen saturation (SpO2) and increased risk of stroke, both of which …

Sickle cell disease (SCD) is a genetic blood disorder that affects hemoglobin and increases
stroke risk, particularly in childhood. This review examines the pathophysiological …

In patients with SCD, chronic liver damage is a common manifestation. More than 50% of
SCD patients have elevated liver enzymes. Common underlying aetiologies include sickle …

Sickle cell disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …

Neurovascular complications represent one of the most detrimental manifestations of Sickle
Cell Disease (SCD), affecting many patients since infancy. They include overt stroke, silent …

Because of its prevalence and severity, sickle cell disease (SCD) is one of the world's major
public health problems. In Africa, the frequency of carriers of the sickle cell gene is variable …

Background Allogeneic hematopoietic stem cell transplantation (HSCT) provides a cure for
patients with sickle cell disease (SCD). This study describes the effect of conditioning …

Background: Sickle cell disease (SCD) is one of the most common hemoglobinopathy
disorders and is widely prevalent in India, especially in the tribal population. SCD patients …